Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4184374 | European Psychiatry | 2012 | 4 Pages |
Abstract
This current study assessed neurocognitive functioning in a carefully selected sample of schizophrenia patients with and without heavy cannabis use and healthy controls. All subjects were negative for any other substance use. Schizophrenia subjects had impaired neurocognitive functions across a wide range of tasks compared to healthy controls. Cannabis using schizophrenia patients had focused impairments on tasks of attention, and the findings suggest an impulsive pattern of response among these patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
S. Lev-Ran, A. Segev, Y. Braw, Y. Levkovitz,